Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1190389017 | Rifampicin+isoniazid 300mg/150mg tablet (product) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| 3471026019 | Product containing rifampin 300 mg and isoniazid 150 mg/1 each oral tablet | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3471027011 | Product containing rifampicin 300 mg and isoniazid 150 mg/1 each oral tablet | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3484062010 | Product containing rifampicin 300 mg and isoniazid 150 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 3500706018 | Rifampicin 300 mg and isoniazid 150 mg oral tablet | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3500707010 | Rifampin 300 mg and isoniazid 150 mg oral tablet | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3566543017 | Product containing only rifampicin 300 mg and isoniazid 150 mg/1 each oral tablet | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3566544011 | Product containing only rifampin 300 mg and isoniazid 150 mg/1 each oral tablet | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3566545012 | Product containing only rifampicin 300 mg and isoniazid 150 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 3682667014 | Isoniazid 150 mg and rifampin 300 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3682668016 | Product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3682669012 | Product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3682670013 | Isoniazid 150 mg and rifampicin 300 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 465397014 | Rifampicin+isoniazid 300mg/150mg tablet | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 717963017 | Rifampicin+isoniazid 300mg/150mg tablet (substance) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Is a | Isoniazid and rifampicin only product in oral dose form | true | Inferred relationship | Some | ||
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Plays role | Antitubercular therapeutic role | true | Inferred relationship | Some | ||
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has precise active ingredient | Rifampicin | true | Inferred relationship | Some | 1 | |
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has BoSS | Isoniazid | true | Inferred relationship | Some | 2 | |
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has BoSS | Rifampicin | true | Inferred relationship | Some | 1 | |
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has precise active ingredient | Isoniazid | true | Inferred relationship | Some | 2 | |
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Is a | Isoniazid- and rifampicin-containing product | false | Inferred relationship | Some | ||
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has active ingredient | Isoniazid | false | Inferred relationship | Some | ||
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has active ingredient | Hydrazine | false | Inferred relationship | Some | ||
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has active ingredient | Rifampicin | false | Inferred relationship | Some | ||
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Some | ||
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Is a | Rifampicin-containing product in oral dose form | false | Inferred relationship | Some | ||
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Is a | Isoniazid-containing product in oral dose form | false | Inferred relationship | Some | ||
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Is a | Isoniazid- and rifampicin-containing product in oral dose form | false | Inferred relationship | Some | ||
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has active ingredient | Isoniazid | false | Inferred relationship | Some | 1 | |
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has BoSS | Isoniazid | false | Inferred relationship | Some | 1 | |
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has presentation strength numerator value | 150 | false | Inferred relationship | Some | 1 | |
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has active ingredient | Rifampicin | false | Inferred relationship | Some | 2 | |
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has BoSS | Rifampicin | false | Inferred relationship | Some | 2 | |
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has presentation strength numerator value | 300 | false | Inferred relationship | Some | 2 | |
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 2 | |
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has active ingredient | Rifampicin | false | Inferred relationship | Some | ||
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has active ingredient | Isoniazid | false | Inferred relationship | Some | ||
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has precise active ingredient | Rifampicin | false | Inferred relationship | Some | 2 | |
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has precise active ingredient | Isoniazid | false | Inferred relationship | Some | 1 | |
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
| Isoniazid 150 mg and rifampicin 300 mg oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR